cyclosporine has been researched along with Hematologic Malignancies in 138 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (9.42) | 18.2507 |
| 2000's | 73 (52.90) | 29.6817 |
| 2010's | 46 (33.33) | 24.3611 |
| 2020's | 6 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Akpinar, S; Kayikci, O; Tekgunduz, E | 1 |
| Akdemir, NB; Büyükaşık, Y; Demiroğlu, H; Göker, H; Haznedaroğlu, İC; Karakulak, EA; Malkan, ÜY; Özcebe, Oİ; Sayınalp, N; Tekin, F | 1 |
| Fan, Z; Huang, F; Lai, Y; Lin, R; Liu, Q; Lv, W; Qu, H; Sun, J; Wu, M; Xu, N; Xu, Y; Xuan, L; Zhao, K | 1 |
| Ding, XL; Liu, LN; Miao, LY; Tian, JX; Xue, L; Yan, HH; Zhang, JJ; Zhang, WJ; Zhang, WW | 1 |
| Couban, S; Couture, F; Devins, G; Elemary, M; Foley, R; Gallagher, G; Kerr, H; Kuruvilla, J; Lee, SJ; Moore, J; Nevill, T; Panzarella, T; Popradi, G; Roy, J; Schultz, KR; Szwajcer, D; Toze, C; Walker, I | 1 |
| García-Basas, L; Gómez de Salazar-López de Silanes, E; Herrera-Puente, P; Núñez-Torrón-Stock, C; Pueyo-López, C; Sánchez-Cuervo, M | 1 |
| Chang, YJ; Chen, FP; Du, X; Hu, J; Hu, JD; Hu, Y; Huang, H; Huang, XJ; Jiang, M; Lai, YR; Li, J; Li, W; Li, YH; Liang, YM; Lin, DJ; Liu, QF; Ren, HY; Song, YP; Sun, YQ; Wang, JB; Wang, SQ; Wu, DP; Xiao, Y; Zhang, X; Zhou, JF | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Afanasyev, BV; Bondarenko, SN; Burmina, EA; Darskaya, EI; Moiseev, IS; Muslimov, AR; Pirogova, OV; Senina, NG; Tarakanova, YA | 1 |
| Corradini, P; Greco, R; Mussetti, A; Peccatori, J | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| Han, Y; Qiu, H; Sun, A; Tang, X; Wu, D; Yang, S; Yang, X | 1 |
| Endo, T; Fujimoto, K; Goto, H; Hashimoto, D; Hayase, E; Hidaka, D; Ishio, T; Kahata, K; Kondo, T; Nakagawa, M; Okada, K; Onozawa, M; Shiratori, S; Sugita, J; Tateno, T; Teshima, T | 1 |
| Akahane, D; Gotoh, M; Kobayashi, C; Ohyashiki, JH; Ohyashiki, K; Saitoh, Y; Umezu, T; Yoshizawa, S | 1 |
| Adaeva, R; Banet, A; Bastos, J; Battipaglia, G; Belhocine, R; Brissot, E; de Wyngaert, ZV; Duléry, R; Giannotti, F; Isnard, F; Lapusan, S; Ledraa, T; Legrand, O; Malard, F; Médiavilla, C; Mohty, M; Paviglianiti, A; Rubio, MT; Ruggeri, A; Sestili, S; Vekhoff, A | 1 |
| Blijlevens, NMA; Bremmers, MEJ; Brüggemann, RJM; de Kort, EA; de Lil, HS; Huls, G; van der Velden, WJFM; van Dorp, S; van Groningen, LFJ | 1 |
| Battipaglia, G; Bazarbachi, A; Belhocine, R; Brissot, E; Duléry, R; Ledraa, T; Malard, F; Médiavilla, C; Mohty, M; Mohty, R; Paviglianiti, A; Ruggeri, A; Sestili, S; Stocker, N; Vekhoff, A | 1 |
| Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X | 1 |
| Arora, M; Blazar, BR; Brunstein, CG; DeFor, TE; Fargen, AD; Rogosheske, JR; Warlick, E; Weisdorf, DJ | 1 |
| Ichikawa, M; Kurokawa, M; Nannya, Y; Nasu, R; Shinohara, A | 1 |
| Ding, KY; Geng, LQ; Liu, HL; Song, KD; Sun, ZM; Tang, BL; Tong, J; Wang, XB; Wang, Y; Wei, W; Yao, W; Zheng, CC; Zhou, CY; Zhu, XY | 1 |
| Kanakry, CG; Luznik, L | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
| Avraham, GP; Brammer, JE; Curtin, P; Frires, R; Gajewski, J; Hayes-Lattin, B; Kovacsovics, T; Leis, JF; Maziarz, RT; Meyers, G; Nemecek, E; Palmbach, G; Slater, S; Stentz, A; Subbiah, N | 1 |
| Bigley, V; Collin, M; Dickinson, A; Hale, G; Jackson, G; Jardine, L; Pearce, K; Publicover, A | 1 |
| Didsbury, MS; Kennedy, SE; Mackie, FE | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, FR; Wang, JZ; Wang, Y; Xu, LP; Yan, CH | 1 |
| Arai, Y; Atsuta, Y; Eto, T; Fukuda, T; Hirokawa, M; Iwato, K; Kaida, K; Kanda, J; Kanda, Y; Kondo, T; Morishima, Y; Murata, M; Nagamura-Inoue, T; Nakamae, H; Nakasone, H; Ohashi, K; Uchida, N | 1 |
| Ashizawa, M; Doki, N; Kakihana, K; Kako, S; Kanamori, H; Kanda, Y; Kato, J; Kikuchi, M; Kimura, SI; Kobayashi, T; Mori, T; Nakaseko, C; Okamoto, S; Tanaka, M; Tanihara, A; Watanabe, R; Yokota, A | 1 |
| Blaise, D; Bramanti, S; Carlo-Stella, C; Castagna, L; Chabannon, C; Cheikh, JE; Crocchiolo, R; Devillier, R; El-Cheikh, J; Faucher, C; Furst, S; Giordano, L; Granata, A; Harbi, S; Mauro, E; Mohty, B; Morabito, L; Santoro, A; Sarina, B | 1 |
| Goyal, RK; Howrie, D; Joshi, R; Kenkre, TS; Venkataramanan, R; Windreich, RM | 1 |
| Davies, SM; Filipovich, AH; Grimley, MS; Khandelwal, P; Lane, A; Marsh, RA; Mellor-Heineke, S; Rehman, N; Smiley, K; Villanueva, J | 1 |
| Gao, ZY; Li, WD; Lu, DP; Lu, DY; Yu, XJ | 1 |
| Ding, KY; Geng, LQ; Han, YS; Liu, HL; Liu, X; Sun, ZM; Tang, BL; Tong, J; Wan, X; Wang, XB; Wang, ZY; Wu, JS; Wu, Y; Yang, HZ; Yao, W; Zhang, L; Zhang, XH; Zheng, CC; Zhu, WW; Zhu, XY | 1 |
| Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, TE; Holtan, SG; Jacobson, PA; Lazaryan, A; MacMillan, ML; Rogosheske, J; Verneris, MR; Wagner, JE; Weisdorf, DJ | 1 |
| André, N; Boulamery, A; Coze, C; Dupouey, J; Galambrun, C; Guilhaumou, R; Marsot, A; Simon, N | 1 |
| Akashi, K; Eto, T; Henzan, H; Iwasaki, H; Kamimura, T; Kato, K; Miyamoto, T; Nagafuji, K; Osaki, K; Takase, K; Takashima, S; Teshima, T; Yoshida, S; Yoshimoto, G | 1 |
| Chen, X; Du, X; Gao, L; Kong, P; Li, H; Liu, H; Liu, J; Liu, Y; Peng, X; Su, Y; Sun, A; Zhang, C; Zhang, X; Zhang, Y; Zhong, J | 1 |
| Bollea-Garlatti, ML; Galimberti, RL; Torre, AC; Vacas, AS; Warley, F | 1 |
| Beijnen, JH; Bosch, TM; Huijgens, PC; Kessels, LW; Timmers, GJ; Veldkamp, AI; Wilhelm, AJ | 1 |
| Geng, LQ; Liu, HL; Sun, ZM; Tong, J; Wang, ZY; Yao, W; Yuan, X | 1 |
| Andree, H; Freund, M; Hilgendorf, I; Holzhueter, S; Junghanss, C; Leithaeuser, M; Loddenkemper, C; Steiner, B; Wolff, D | 1 |
| Kersting, S; Verdonck, LF | 1 |
| Abdelhaleem, M; Benseler, S; Gupta, AA; Tyrrell, P; Valani, R; Weitzman, S | 1 |
| Arai, S; Blume, KG; Heydari, K; Hoppe, RT; Johnston, LJ; Kohrt, HE; Laport, GG; Lavori, PW; Lowsky, R; Miklos, DB; Negrin, RS; Shizuru, JA; Strober, S; Turnbull, BB; Weng, WK | 1 |
| Balduzzi, A; Cesaro, S; Dini, G; Favre, C; Lanino, E; Locatelli, F; Messina, C; Pession, A; Pollichieni, S; Rabusin, M; Rondelli, R; Santarone, S | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Bahceci, E; Devetten, M; Herzig, R; Holland, K; Isola, L; Jansen, J; Kebriaei, P; McGuirk, J; Monroy, R; Rowley, S; Schuster, M; Uberti, J | 1 |
| He, L; Ji, BS | 1 |
| Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 2 |
| Al-Ghamdi, A; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Ayas, M; Chaudhri, N; Mohammed, SY; Nassar, A; Tabbara, KF | 1 |
| den Hartigh, J; Egeler, RM; Lankester, AC; Press, RR; Vossen, JM; Willemze, AJ | 1 |
| Chang, YJ; Huang, XJ; Huo, MR; Liu, DH; Liu, KY; Xu, LP; Zhao, XY | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Maloney, DG; Martin, PJ; Mielcarek, M; Peffer, A; Rotta, M; Sandmaier, BM; Storb, R; Storer, BE; Vernon, MS | 1 |
| Abdelqader, S; Abonour, R; Baute, J; Cornetta, K; Farag, SS; Fausel, CA; Kalsekar, I; Kiel, PJ; Nelson, RP; Robertson, MJ; Rosenbeck, LL; Schwartz, J; Srivastava, S; Sullivan, CK; Vargo, C; Wood, L | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Flowers, ME; Furlong, T; Inamoto, Y; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, RF; Storer, BE; Witherspoon, RP | 1 |
| Akiyama, H; Kakihana, K; Kobayashi, T; Murata, Y; Ohashi, K; Sakamaki, H; Tsubokura, M; Yamashita, T | 1 |
| Antin, JH | 1 |
| Claxton, D; Ehmann, WC; Karch, J; Zhu, J | 1 |
| Aglietta, M; Boccadoro, M; Bruno, B; Casini, M; Cavattoni, I; Console, G; Festuccia, M; Filippi, AR; Gallamini, A; Giaccone, L; Gigli, F; Irrera, G; Levis, A; Messina, G; Montanari, M; Mordini, N; Passera, R; Pastano, R; Pini, M; Ricardi, U; Risitano, AM; Schianca, FC; Scortechini, I; Selleri, C; Sorasio, R | 1 |
| Aker, M; Dray, L; Grisariu, S; Kedmi, M; Or, R; Resnick, IB; Shapira, MY; Stepensky, P | 1 |
| Caballero, D; Cabrero, M; Lopez-Corral, L; Márquez-Malaver, FJ; Martinez, C; Martino, R; Parody, R; Perez-Simón, JA; Sierra, J; Solano, C; Valcarcel, D; Vazquez, L | 1 |
| Fujisawa, S; Fujita, H; Kanamori, H; Kanda, Y; Kobayashi, T; Mori, T; Nakaseko, C; Nannya, Y; Ohashi, K; Okamoto, S; Sakamaki, H; Sakura, T; Takahashi, S; Tanaka, M; Yokota, A | 1 |
| Cavenagh, J; Chopra, R; Clark, FJ; Culligan, D; Davies, A; Fuller, S; Hunt, L; Hunter, A; Littlewood, T; Lush, R; Marks, DI; Marsh, J; Milligan, DW; Parker, A; Schey, S; Smith, GM; Towlson, K; Vandenberghe, E; Williams, CD; Yin, J | 1 |
| Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
| Agura, E; Blume, KG; Bruno, B; Chauncey, TR; Feinstein, L; Forman, S; Georges, GE; Hegenbart, U; Little, MT; Malone, DG; Maris, M; McSweeney, PA; Niederweiser, D; Pulsipher, MA; Radich, JP; Sahebi, F; Sandmaier, BM; Shizuru, JA; Storb, R; Woolfrey, AE | 1 |
| Calevo, MG; Castagnola, E; Dallorso, S; Dini, G; Faraci, M; Fondelli, MP; Gaggero, R; Haupt, R; Lanino, E; Manzitti, C; Morreale, G | 1 |
| Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
| Arcese, W; Cerilli, L; Cerretti, R; De Felice, L; De Propris, MS; Fenu, S; Girelli, G; Iori, AP; Mengarelli, A; Moleti, ML; Romano, A | 1 |
| Flowers, ME; Leisenring, W; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Agura, EA; Blume, KG; Chauncey, TR; Feinstein, LC; Forman, SJ; Gooley, TA; Hegenbart, U; Maloney, DG; Maris, MB; McSweeney, PA; Niederwieser, DW; Pulsipher, MA; Sandmaier, BM; Storb, RF; Stuart, MJ | 1 |
| Bravo-Hernández, G; Estrada, E; Gómez-Rangel, D; López-Martínez, B; Manuel Hernández, J; Marín-López, A; Ruiz-Argüelles, GJ | 1 |
| Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
| Kawano, Y; Koga, Y; Nagatoshi, Y; Okamura, J | 1 |
| Beelen, DW; Schulte, CM | 1 |
| Höffken, K; Issa, MC; Kasper, C; Mügge, LO; Sayer, HG; Schilling, K; Scholl, S | 1 |
| Amadori, S; Ballatore, G; Caravita, T; Catalano, G; Cristina Cox, M; Cudillo, L; Cupelli, L; Dentamaro, T; Fabritiis Pd, Pd; Picardi, A; Venditti, A | 1 |
| Bargetzi, M; Chklovskaia, E; Gratwohl, A; Nissen, C; Nowbakht, P; Wodnar-Filipowicz, A | 1 |
| Chan, G; Foss, FM; Gorgun, G; Grodman, H; Lawrence, D; Mahajan, A; Miller, KB; Relias, V; Roberts, TF; Schenkein, DP; Sprague, K | 1 |
| Al-Kadhimi, Z; Angelopoulou, M; Cohen, S; Falk, PM; Forman, SJ; Fung, HC; Kogut, N; Krishnan, AY; Nademanee, A; O'Donnell, MR; Parker, P; Popplewell, L; Rodriguez, R; Sahebi, F; Schriber, J; Senitzer, D; Slovak, M; Smith, D; Snyder, DS; Somlo, G; Spielberger, R; Stein, A | 1 |
| Andresen, S; Bolwell, B; Kalaycio, M; Kuczkowski, E; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Kari, JA; Trompeter, RS | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Anasetti, C; Appelbaum, FR; Blume, KG; Deeg, HJ; Forman, SJ; Furlong, T; Johnston, L; Kiem, HP; Lloid, ME; Martin, PJ; McCune, JS; Nash, RA; Parker, P; Schubert, MM; Slattery, JT; Storb, R; Storer, B; Witherspoon, RP | 1 |
| Bartynski, WS; Lister, J; Shadduck, RK; Zeigler, ZR | 1 |
| Fujimori, Y; Hara, H; Itoi, H; Itsukuma, T; Kai, S; Misawa, M; Nakajima, T; Nishioka, K; Nomura, K; Ogawa, H; Okada, M; Takatsuka, H; Toda, A; Wakae, T | 1 |
| Boyette, RM; Leather, H; Tian, L; Wingard, JR | 1 |
| Hara, M; Kozuka, T; Maeda, Y; Nakase, K; Nawa, Y; Tanimoto, K | 1 |
| Agura, E; Blume, KG; Bruno, B; Chauncey, TR; Kliem, C; Langston, AA; Maloney, DG; Maris, MB; Maziarz, RT; McSweeney, PA; Pulsipher, M; Sandmaier, BM; Shizuru, JA; Storb, R; Storer, BE; Wade, J | 1 |
| Baron, F; Bruno, B; Burroughs, L; Chauncey, TR; Flowers, ME; Forman, SJ; Leisenring, W; Maloney, DG; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Bambach, B; Benekli, M; Cooper, M; Hahn, T; McCarthy, PL; Roy, HN; Stewart, C; Wallace, P; Williams, BT | 1 |
| Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
| Jiang, XF; Sheng, BJ | 1 |
| Hillyer, CD; O'Reilly, KC; Roback, JD; Schniederjan, SD; Sheppard, CA | 1 |
| Altuntas, F; Cetin, M; Eser, B; Fen, T; Ferahbas, A; Kocyigit, I; Ozturk, A; Sari, I; Sisman, Y; Unal, A | 1 |
| Hamaguchi, M; Iida, H; Kohno, A; Matsuo, K; Miyamura, K; Morishita, Y; Murata, M; Narimatsu, H; Oba, T; Sawa, M; Terakura, S; Uchida, T; Watanabe, M | 1 |
| Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
| Daffy, JR; Morrissey, CO; O'Reilly, MA; Schwarer, AP; Seymour, JF; Slavin, MA; Szer, J | 1 |
| Boga, C; Haberal, M; Karakus, S; Kizilkilic, E; Kozanoglu, I; Ozdogu, H; Sahin, FI; Unalan, D | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Hamaki, T; Hori, A; Kami, M; Kanda, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Tanaka, Y; Taniguchi, S; Uchida, N; Wake, A; Yuji, K | 1 |
| Bessho, M; Dan, K; Fujishima, N; Hirokawa, M; Nakao, S; Omine, M; Ozawa, K; Sawada, K; Teramura, M; Tsurumi, H; Urabe, A | 1 |
| Arn, JS; Billiter, RA; Cho, PS; Coburn, RC; Goodrich, JG; Houser, SL; Huang, CA; Lo, DP; McMorrow, IM; Rowland, HC; Sachs, DH; Shimizu, A; Wikiel, KJ; Yang, YG | 1 |
| Kline, J; Lazarus, HM; Subbiah, S; van Besien, K | 1 |
| Asano, S; Hongo, E; Kasahara, S; Kato, S; Konuma, T; Kurokawa, Y; Mae, H; Oiwa-Monna, M; Ooi, J; Takahashi, S; Tojo, A; Tomonari, A; Tsukada, N | 1 |
| Caballero, D; Calvo, MV; de la Cámara, R; de Oteiza, JP; Heras, I; Martino, R; Pérez-Simón, JA; Rebollo, N; San Miguel, JF; Sierra, J; Valcarcel, D | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Alegre, A; Benet, I; Besalduch, J; Brunet, S; Carreras, E; de la Rubia, J; Díaz, MA; Domingo-Albós, A; García-Conde, J; Hernández, F; Moraleda, JM; Ojeda, E; Petit, J; Rozman, C; Sanz, G; Solano, C; Urbano-Ispizua, A; Vivancos, P | 1 |
| Appelbaum, FR; Bensinger, WI; Benyunes, M; Buckner, CD; Clift, R; Demirer, T; Lee, M; Martin, P; Rowley, S; Schiller, G; Shannon-Dorcy, K; Storb, R | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Fridborg, H; Kristensen, J; Larsson, R; Martinsson, P; Nilsson, K; Nygren, P | 1 |
| Abraham, R; Bardy, P; Grigg, A; Szer, J | 1 |
| Fuchs, D; Gruhn, B; Häfer, R; Kosmehl, H; Zintl, F | 1 |
| Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
| Barrett, AJ; Childs, R; Dunbar, C; Engler, H; Phang, S; Plante, M; Preuss, J; Rosenfeld, S; Sanchez, C; van Rhee, F | 1 |
| Abrams, R; Ambinder, RF; Braine, HG; Flinn, I; Grever, M; Griffin, C; Hess, AD; Jones, RJ; Marcellus, DC; Miller, C; Noga, SJ; O'Donnell, PV; Piantadosi, S; Seber, A; Vogelsang, GB | 1 |
| Dieckman, K; Fischer, G; Greinix, HT; Kalhs, P; Keil, F; Lechner, K; Leitner, G; Malzer, R; Rabitsch, W; Reiter, E | 1 |
| Bátorová, A; Bojtárová, E; Buc, M; Demecková, E; Fehérvízyová, E; Holománová, D; Hrubisko, M; Kusiková, M; Mistrík, M; Sakalová, A | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Andrews, D; Colby, C; Cox, B; Foley, A; McAfee, S; Multani, P; Poliquin, C; Preffer, F; Sachs, DH; Sackstein, R; Saidman, S; Spitzer, TR; Sykes, M; Toh, HC; Weyouth, DW | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Leisenring, W; Martin, PJ; Storb, RF | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
| Chklovskaia, E; Landmann, L; Nissen, C; Pfister, O; Rahner, C; Wodnar-Filipowicz, A | 1 |
| Barbui, T; Caruso, R; Dotti, G; Gaspari, F; Perico, N; Rambaldi, A; Remuzzi, G | 1 |
| Appelbaum, FR; Bensinger, WI; Blume, KG; Bryant, E; Chauncey, TR; Flowers, ME; Georges, GE; Gooley, TA; Grumet, FC; Hegenbart, U; Kiem, HP; Maloney, DG; McSweeney, PA; Minor, S; Molina, AJ; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, BM; Shizuru, JA; Storb, RF; Torok-Storb, B; Wagner, JL; Yu, C | 1 |
| Ilan, Y; Menachem, Y; Nagler, A | 1 |
| Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
| Blume, KG; Chauncey, T; Forman, S; Maloney, DG; Maris, M; McSweeney, PA; Niederwieser, D; Sandmaier, BM; Shizuru, J; Storb, R; Woolfrey, A | 1 |
| Derigs, HG; Fischer, T; Huber, C; Kolbe, K; Kreiter, S; Schneider, PM; Schuler, M; Ullmann, AJ; Winkelmann, N | 1 |
| Aotsuka, N; Fujimaki, K; Fujisawa, S; Kanamori, H; Maruta, A; Matsuzaki, M; Okamoto, S; Saito, K; Sakamaki, H; Takahashi, S | 1 |
| Alessandrino, PE; Bacigalupo, A; Barbanti, M; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; Van Lint, MT | 1 |
| Grignard, F; Schots, R; Trullemans, F; Van Camp, B | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Gooley, T; Kansu, E; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H | 1 |
7 review(s) available for cyclosporine and Hematologic Malignancies
| Article | Year |
|---|---|
Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplanta
Topics: Adult; Aged; Animals; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polydeoxyribonucleotides; Rabbits; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2022 |
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
Topics: Acute Disease; Allografts; Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Sirolimus | 2017 |
A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients.
Topics: Acute Kidney Injury; Adolescent; Amphotericin B; Biomarkers; Child; Cyclosporine; Foscarnet; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Prognosis; Risk Factors; Transplantation, Homologous; Treatment Outcome | 2015 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus | 2004 |
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Topics: Animals; Antiviral Agents; Autoimmune Diseases; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Mice; Models, Animal; Self Tolerance; Transplantation, Autologous | 2008 |
Non-myeloablative hematopoietic stem cell transplantation.
Topics: Animals; Bone Marrow; Chimera; Cyclosporine; Dogs; Drug Administration Schedule; Graft Rejection; Graft Survival; Graft vs Host Reaction; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Models, Animal; Mycophenolic Acid; Safety; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2001 |
55 trial(s) available for cyclosporine and Hematologic Malignancies
| Article | Year |
|---|---|
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Models, Biological; Reproducibility of Results; Transplantation Conditioning; Voriconazole | 2019 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Reported Outcome Measures; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2020 |
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Siblings; Tissue Donors; Transplantation Conditioning | 2020 |
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources.
Topics: Adolescent; Adult; Aged; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Predictive Value of Tests; Remission Induction; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning | 2018 |
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Rate; T-Lymphocytes; Thiotepa; Transplantation Conditioning; Vidarabine | 2019 |
Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.
Topics: Adolescent; Adult; Allografts; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Living Donors; Male; Middle Aged; Mycophenolic Acid; Quality of Life; Siblings; Survival Rate; Transplantation Conditioning; Unrelated Donors | 2014 |
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Topics: Aged; Antineoplastic Agents; Busulfan; Cyclosporine; Female; Frail Elderly; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine; Whole-Body Irradiation | 2015 |
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Registries; Risk Factors; Survival Rate | 2016 |
A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.
Topics: Acute Disease; Adult; Allografts; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Middle Aged; Survival Rate; Tacrolimus; Unrelated Donors | 2016 |
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
Topics: Adult; Aged; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Premedication; Sirolimus; Survival Analysis; Time Factors; Transplantation Conditioning; Young Adult | 2016 |
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphocyte Subsets; Male; Middle Aged; Premedication; Recurrence; Survival Rate; Tacrolimus; Young Adult | 2017 |
Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Female; Genotype; Half-Life; Hematologic Neoplasms; Humans; Hydroxylation; Immunosuppressive Agents; Injections, Intravenous; Itraconazole; Male; Middle Aged; Pilot Projects; Polymorphism, Single Nucleotide; Prospective Studies | 2008 |
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.
Topics: Adult; Aged; Anti-Infective Agents; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Lymphatic Irradiation; Male; Middle Aged; Mycophenolic Acid; Premedication; Risk; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2009 |
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Topics: Adolescent; Child; Child, Preschool; Communicable Diseases; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Postoperative Complications; Prospective Studies; Recurrence; Transplantation, Homologous | 2009 |
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Mycophenolic Acid; Tacrolimus | 2009 |
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Clofarabine and CY do not yield reliable engraftment of hematopoietic stem cells.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Cyclosporine; Female; Graft Survival; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous | 2012 |
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Survival Rate; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2013 |
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Prospective Studies; Risk; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation | 2013 |
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Middle Aged; Mycophenolic Acid; Tissue Donors; Transplantation Conditioning; Transplantation Immunology; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2002 |
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Middle Aged; Mycophenolic Acid; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2003 |
Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japa
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Infant; Japan; Male; Methotrexate; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2003 |
Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.
Topics: Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Calcium; Cohort Studies; Cyclosporine; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Prospective Studies; Risk Factors; Steroids; Transplantation, Homologous; Vitamin D | 2004 |
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors.
Topics: Adult; Blood Donors; Cyclosporine; Cytomegalovirus; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Virus Activation | 2004 |
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Topics: Adult; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand.
Topics: Adolescent; Adult; Cell Lineage; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Killer Cells, Natural; Kinetics; Membrane Proteins; Middle Aged; Regeneration; Transplantation, Homologous | 2004 |
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Pentostatin; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2004 |
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Premedication; Prospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2004 |
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2004 |
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning; Transplantation, Homologous | 2005 |
Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adult; Antifungal Agents; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Itraconazole; Male; Middle Aged; Prospective Studies; Tacrolimus; Transplantation, Homologous | 2006 |
Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.
Topics: Adolescent; Adult; Alleles; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Pharmacokinetics; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2006 |
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Remission Induction; Survival Rate; Transplantation Conditioning; Vidarabine | 2006 |
Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD3 Complex; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; T-Lymphocytes; Transplantation, Homologous | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Topics: Adult; Aged; Antigens, CD34; Blood Cells; Cell Count; Cell Separation; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants.
Topics: Adolescent; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Graft vs Host Reaction; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Living Donors; Male; Middle Aged; Nuclear Family; Treatment Outcome | 1997 |
Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Prospective Studies; Skin; Transplantation, Autologous | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation Chimera; Transplantation, Homologous | 1998 |
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Topics: Adult; Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Genotype; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Heart Diseases; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Leukocyte Transfusion; Male; Mice; Middle Aged; Models, Animal; Phenotype; Remission Induction; Reproducibility of Results; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Middle Aged; Time Factors | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Topics: Adult; Aged; Area Under Curve; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation, Homologous | 2001 |
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Topics: Adult; Aged; Aging; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Neutrophils; Platelet Count; Remission Induction; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
[Feasibility of early tapering and discontinuation of cyclosporine to intensify the graft-versus-leukemia effect in patients with advanced hematologic neoplasms].
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Feasibility Studies; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2001 |
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infection Control; Italy; Life Tables; Male; Methotrexate; Middle Aged; Rabbits; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Topics: Adult; Biopsy; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Prospective Studies; Risk Factors; Skin; Survival Rate; Time Factors; Transplantation, Homologous | 2001 |
76 other study(ies) available for cyclosporine and Hematologic Malignancies
| Article | Year |
|---|---|
A single-center experience of haploidentical stem cell transplantation in hematological malignancies.
Topics: Busulfan; Child; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Prospective Studies; Retrospective Studies | 2023 |
Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anemia, Hemolytic, Autoimmune; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Haploidentical; Transplantation, Homologous; Young Adult | 2019 |
Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation.
Topics: Adult; Anti-Infective Agents; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Patient Compliance; Retrospective Studies; Treatment Outcome | 2020 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Risk Factors; Survival Analysis; Tacrolimus; Transplantation, Homologous; Young Adult | 2017 |
Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; T-Lymphocytes; Transplantation Conditioning; Transplantation, Haploidentical; Transplantation, Homologous; Young Adult | 2018 |
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Exosomes; Female; Gene Expression Profiling; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; MicroRNAs; Middle Aged; Myeloablative Agonists; ROC Curve; Survival Analysis; Tacrolimus; Transplantation, Homologous | 2018 |
Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adult; Aged; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney; Liver; Male; Middle Aged; Netherlands; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Water-Electrolyte Imbalance; Young Adult | 2019 |
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Risk Factors; Time-to-Treatment; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome; Young Adult | 2019 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult | 2013 |
Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival.
Topics: Adolescent; Adult; Alleles; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Risk Factors; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2014 |
Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Survival Rate; Tacrolimus; Treatment Outcome; Young Adult | 2014 |
Are alternative donors really still "alternative?".
Topics: Bone Marrow Transplantation; Cyclosporine; Gene Expression; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Recurrence; Siblings; Survival Analysis; Transplantation, Homologous; Unrelated Donors | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retrospective Studies; Transplantation Chimera; Transplantation Conditioning; Unrelated Donors | 2015 |
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Transplantation, Homologous; Young Adult | 2015 |
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.
Topics: Adult; Allografts; Cyclophosphamide; Cyclosporine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2016 |
A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
Topics: Adolescent; Adult; Area Under Curve; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Half-Life; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Mycophenolic Acid; Myeloablative Agonists; Pilot Projects; Prospective Studies; Survival Analysis; Transplantation Conditioning | 2016 |
Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Topics: Acute Disease; Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Cytokines; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Inflammasomes; Male; Myeloablative Agonists; Prospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2016 |
[Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies].
Topics: Antilymphocyte Serum; Busulfan; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Leukemia; Mycophenolic Acid; Stem Cell Transplantation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
[Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; China; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Male; Retrospective Studies; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2016 |
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
Topics: Anti-Bacterial Agents; Child; Cyclosporine; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin | 2016 |
Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2017 |
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Topics: Adalimumab; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Etanercept; Female; Glucocorticoids; Hematologic Neoplasms; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Middle Aged; Prednisone; Pyoderma Gangrenosum; Retrospective Studies; Sex Factors; Survival Rate | 2017 |
[Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning | 2008 |
Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Budesonide; Chronic Disease; Cyclosporine; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Transplantation, Homologous | 2008 |
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Cyclosporine; Disease-Free Survival; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Topics: Adolescent; Adrenal Cortex Hormones; Cause of Death; Child; Child, Preschool; Cyclosporine; Etoposide; Female; Hematologic Neoplasms; Humans; Immunoglobulins, Intravenous; Infant; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Retrospective Studies; Rheumatic Diseases; Steroids; Virus Diseases | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
CJX1, an amlodipine derivative, interacts with ATPase of human P-glycoprotein.
Topics: Adenosine Triphosphatases; Amlodipine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Calcium Channel Blockers; Cell Line, Tumor; Cyclosporine; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Verapamil | 2009 |
Ocular findings after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Methotrexate; Middle Aged; Ophthalmoscopy; Retrospective Studies; Transplantation, Homologous; Visual Acuity | 2009 |
CsA exposure is associated with acute GVHD and relapse in children after SCT.
Topics: Acute Disease; Adolescent; Area Under Curve; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome; Young Adult | 2009 |
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Interactions; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; T-Lymphocytes; Transplantation, Homologous; Young Adult | 2010 |
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Topics: Adult; Antilymphocyte Serum; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sirolimus; Survival Analysis; Tacrolimus; Thrombotic Microangiopathies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Standard of Care; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
Topics: Adolescent; Adult; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pain; Radiography; Retrospective Studies; Syndrome; Tacrolimus; Transplantation, Homologous | 2012 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Male; Middle Aged; Mycophenolic Acid; Recurrence; Severity of Illness Index; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2012 |
The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioning.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cyclosporine; Cytarabine; Data Collection; Etoposide; Female; Follow-Up Studies; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Severe neurologic complications after hematopoietic stem cell transplantation in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Electroencephalography; Female; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Nervous System Diseases; Neurologic Examination; Neurotoxicity Syndromes; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk; Risk Factors; Transplantation, Homologous | 2003 |
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Topics: Aged; Bone Marrow Transplantation; Busulfan; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Intestines; Life Tables; Liver; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Severity of Illness Index; Skin; Survival Analysis; Time Factors; Tissue Donors; Transplantation Conditioning; Vidarabine; Washington; Whole-Body Irradiation | 2003 |
Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.
Topics: Adolescent; Adult; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Erythrocyte Transfusion; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Platelet Transfusion; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2003 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Ischemic Preconditioning; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Retrospective Studies; Tomography, X-Ray Computed; Transplantation, Homologous | 2005 |
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Topics: Adult; Bone Marrow; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2006 |
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 2006 |
[Clinical study of unrelated umbilical cord blood transplantation in 32 children patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Survival Rate; Transplantation Conditioning | 2006 |
Transfusion medicine illustrated. Detection of mixed-field agglutination due to loss of red cell antigen in hematopoietic malignancy.
Topics: ABO Blood-Group System; Agglutination; Antigens, Surface; Blood Group Incompatibility; Cyclosporine; Erythrocyte Transfusion; Erythrocytes; Female; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Middle Aged; Pancytopenia | 2006 |
The effect of budesonide mouthwash on oral chronic graft versus host disease.
Topics: Adult; Budesonide; Candidiasis, Oral; Chronic Disease; Cohort Studies; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mouthwashes; Pain Measurement; Peripheral Blood Stem Cell Transplantation; Prednisone; Retrospective Studies; Sodium Chloride; Stomatitis; Transplantation Conditioning; Treatment Outcome | 2007 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Cyclosporine; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Transplantation, Homologous; Treatment Outcome | 2007 |
The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Topics: Adult; Aged; Antineoplastic Agents; Communicable Disease Control; Cyclosporine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Mitoxantrone; Patient Selection; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspergillosis, Allergic Bronchopulmonary; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Follow-Up Studies; Fungemia; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Trichosporon | 2007 |
Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cohort Studies; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Health Surveys; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.
Topics: Animals; Cell Line, Tumor; Cyclosporine; Hematologic Neoplasms; Histocompatibility Antigens; Immunosuppressive Agents; Inbreeding; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Swine; Swine Diseases; Swine, Miniature; Whole-Body Irradiation | 2007 |
Early renal injury after myeloablative cord blood transplantation in adults.
Topics: Adult; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vancomycin; Whole-Body Irradiation | 2008 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow; Catheterization, Central Venous; Child; Cyclosporine; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lenograstim; Leukapheresis; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Recombinant Proteins; Retreatment; Retrospective Studies; Safety; Transplantation, Homologous; Treatment Outcome | 1996 |
Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.
Topics: Antineoplastic Agents; Cell Survival; Cyclosporine; Cyclosporins; Drug Screening Assays, Antitumor; Hematologic Neoplasms; Humans; Tumor Cells, Cultured | 1997 |
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.
Topics: Adenoviridae Infections; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cystitis; Female; Hematologic Neoplasms; Hemorrhage; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Middle Aged; Polyomavirus Infections; T-Lymphocytes; Transplantation, Homologous; Tumor Virus Infections | 1998 |
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Allogeneic BMT for haematological disorders: single centre experience of University Hospital Bratislava.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hospitals, University; Humans; Immunosuppressive Agents; Male; Middle Aged; Slovakia; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A.
Topics: Adolescent; Adult; Aged; Cell Membrane; Child; Child, Preschool; Cyclosporine; Cytokines; Female; Golgi Apparatus; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Interleukin-5; Interleukin-7; Lymphocyte Activation; Male; Membrane Proteins; Middle Aged; Pancytopenia; Protein Transport; Receptors, Cytokine; T-Lymphocytes; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous | 2001 |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Cyclosporine; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Prednisone; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation.
Topics: Adult; Chediak-Higashi Syndrome; Cyclosporine; Fatal Outcome; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; T-Lymphocytes; Time Factors; Transplantation Chimera; Transplantation, Homologous; Treatment Failure; Vidarabine; Whole-Body Irradiation | 2001 |
Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Brain; Brain Edema; Cerebellum; Cerebral Cortex; Child; Child, Preschool; Cholesterol; Cyclosporine; Drug Synergism; Female; Follow-Up Studies; Headache; Hematologic Neoplasms; Humans; Hypertension; Immunosuppressive Agents; Infant; Magnesium; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nervous System Diseases; Paresis; Seizures; T-Lymphocytes; Transplantation, Homologous; Vision Disorders | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting | 2001 |